You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Minneapolis, Minnesota 55455

  • Kidney Transplantation


The purpose of this study is to quantitate pre-transplant medication compliance, dialysis compliance, and related psychological variables, and then examine their validity as predictors of post-transplant noncompliant behaviors and clinically relevant outcomes (acute rejection, graft loss, or death). Hypothesis: Noncompliance with pre-transplant medication or with the dialysis prescription, and specific psychological variables predict similarly noncompliant behaviors after transplantation.

Study summary:

This pilot study is intended to provide preliminary data about the feasibility of recruiting a cohort of subjects on hemodialysis and following them prospectively through the transplant procedure. The study will document patient adherence to medications and treatment, both before and after surgery. These preliminary data will permit appropriate design and power calculations for a future study assessing our ability to predict post-transplant compliance, based on pre-transplant behaviors.


Inclusion Criteria: - Adult hemodialysis patients in renal transplant evaluation - Able to read test forms - Responsible for their own medications Exclusion Criteria: - Patients with a major risk of recurrent primary renal disease, e.g. hemolytic uremic syndrome, oxalosis, membranoproliferative glomerulonephritis type II, focal segmental glomerulosclerosis with nephrotic syndrome. - Patients with active psychosis - Patients who do not speak English. - Patients who live and will be followed outside the United States, except Canada. - Patients who are physically unable to open the Medication Event Monitoring System (MEMS) cap. - Patients who are not responsible for taking their own medications, e.g. living in a medical care facility. - Patients who are younger than 14 years old - Patients who will receive an extra renal organ (except pancreas), either simultaneously or previously.



Primary Contact:

Principal Investigator
Thomas E Nevins, MD
University of Minnesota - Clinical and Translational Science Institute

Backup Contact:


Location Contact:

Minneapolis, Minnesota 55455
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.